<DOC>
	<DOCNO>NCT02930668</DOCNO>
	<brief_summary>It proven previous clinical study Glucosanol™ effective safe reduce weight overweight obese . The present study aim expand data concern weight management effect Glucosanol™ overweight moderately obese population .</brief_summary>
	<brief_title>Efficacy Safety Glucosanol™ Body Weight Reduction</brief_title>
	<detailed_description />
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Body Weight</mesh_term>
	<criteria>BMI 25 kg/m2 34,9 kg/m2 Generally good health• Desire lose weight Accustomed regular daily consumption 3 main meal ( breakfast , lunch , dinner ) Consistent stable body weight last 3 month prior V1 ( less 5 % selfreported change ) • Readiness take IP recommend Readiness avoid use weight loss and/or management product and/or program study Readiness adhere diet recommendation study Readiness keep habitual level physical activity prior study study Readiness ability complete subject diary study questionnaire Negative pregnancy test ( beta HCGtest urine ) V1 woman childbearing potential Women childbearing potential : commitment use contraception method Known allergy hypersensitivity component investigational product Known allergy hypersensitivity member Fabaceae family Known food allergy ( e.g . cow 's milk , egg , wheat , crustacean , nuts etc . ) Significant disorder : untreated unstable thyroid gland disorder untreated unstable hypertension ( &gt; 140/90 mm Hg ) acute chronic gastrointestinal ( GI ) disease malabsorption disorder ( e.g . inflammatory bowel disease , coeliac disease , pancreatitis etc . ) diabetes mellitus coagulation disorder serious organ systemic disease could influence conduct and/or outcome study and/or could affect tolerability subject ( opinion investigator ) Significant surgery within last 6 month prior V1 : GI surgery liposuction History eat disorder like bulimia , anorexia nervosa , bingeeating within last 12 monthsprior V1 Clinically relevant excursion safety laboratoryparameters Any electronic medical implant Regular use anticoagulant Regular medication and/or supplementation and/or treatment within last 3 month prior V1 study : could influence body weight ( e.g . systemic corticosteroid ) could influence gastrointestinal function ( e.g . antibiotic , laxative , opioids , glucocorticoid , anticholinergic , antidiarrheal etc . ) per investigator judgement weight management ( e.g . fat binder , carbohydrate/starch blocker , fat burner , satiety product , acupuncture etc . ) Consumption food supplement natural health product duration study Diet lose and/or manage weight ( except accord study protocol ) Vegetarian , vegan macrobiotic diet Smoking cessation within 6 month prior V1 study ( regular smoking study level prior study allow ) Pregnancy nurse History current abuse drug , alcohol medication Inability comply study requirement Subjects deprive freedom administrative legal decision guardianship Participation another clinical study 30 day prior V1 study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>